Contrast Enhanced Ultrasound and Urine Mass Spectometry in Patients with Hepatocellular Adenoma
Completed
- Conditions
- Liver adenoma1001965410019813
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 78
Inclusion Criteria
Persons 18 years and older, discharged from follow-up of the Erasmus MC with the diagnosis or probable diagnosis of hepatocellular adenoma. Informed consent must be signed.
Exclusion Criteria
Persons under 18 years.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>What is the sensitivity of CEUS with SonoVue compared to diagnostic modalities<br /><br>conducted in the past (radiology, histology)? </p><br>
- Secondary Outcome Measures
Name Time Method <p>What is the behavior of hepatocellular adenoma during and after menopause?<br /><br>Is it possible to classify hepatocellular adenoma, according to the subgroups<br /><br>of the Bordeaux group, based on contrast ultrasonography?<br /><br>Are there specific biomarkers (natural peptides and metabolites) in urine that<br /><br>can demonstrate hepatocellular adenoma?<br /><br>What is the quality of life of patients with hepatocellular adenoma?<br /><br>1. with certainty of hepatocellular adenoma (> 6 months ago)<br /><br>2. who are in a diagnostic process for hepatocellular adenoma</p><br>